37 participants
Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2026-04-01
- Completion:
- 2030-07-28
Conditions
- Melanoma Metastatic
- NRAS Mutation
Interventions
- DRUG
No Results Yet